Is Godavari Drugs Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Godavari Drugs Ltd (530317.BO) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Godavari Drugs Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Godavari Drugs Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Godavari Drugs Ltd?

Muslim investors may consider investing in Godavari Drugs Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Godavari Drugs Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Godavari Drugs Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Godavari Drugs Ltd updated?

The Shariah compliance status of Godavari Drugs Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Godavari Drugs Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Godavari Drugs Ltd?

You can check the latest Shariah compliance status of Godavari Drugs Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Godavari Drugs Ltd 530317.BO

₹125.70 ₹3.80 (2.93%) 1D

Last Updated: May 15, 12:00 AM·BSE

530317.BO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 27, 2026

Report Source: 2026 2nd Quarter Report

Godavari Drugs Ltd. Stock Analysis 530317.BO

India Health Care Nano Cap Report: Q2, 2026

Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. The company is headquartered in Secunderabad, Telangana and currently employs 106 full-time employees. The firm is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The company operates through manufacture and sale of API and its intermediates segment. Its manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The firm's facility has multiple production blocks for API's, drug intermediates and fine chemicals.

Key Statistics of Godavari Drugs Ltd (530317.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹125.70₹130.50

Today's Open

₹129.50

Volume

6597.00

P/E Ratio (TTM)

29.13

52 Week Range

₹69.70₹134.50

Market Cap

757.45M

Avg. Volume

19.67K

Dividend Yield

Financial Metrics & Statements of Godavari Drugs Ltd (530317.BO)

FAQ's for Godavari Drugs Ltd (530317.BO)

According to Musaffa’s Shariah screening methodology, Godavari Drugs Ltd (530317.BO) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.